PKD2L2 divergent transcript (PKD2L2-DT)

PKD2L2-DT stands for "PKD2L2 divergent transcript," which is a non-coding RNA annotated in the human genome and affiliated with the long non-coding RNA (lncRNA) class[5]. Unlike the protein-coding PKD2L2 gene (Polycystin 2 Like 2, Transient Receptor Potential Cation Channel), PKD2L2-DT does not encode a functional protein and is not considered a canonical therapeutic target or receptor[3][5]. There is currently little direct information published about PKD2L2-DT’s biological function, molecular pathway involvement, or its relevance in disease beyond database entries linking it to rare myopathies[5]. No drugs, biomarkers, safety issues, or mechanism of action have been documented for PKD2L2-DT. Its frequent confusion with the PKD2L2 protein-coding gene means caution should be used; when searching for a druggable target, "PKD2L2-DT" is not appropriate[3][5]. PKD2L2-DT is a long non-coding RNA, not a conventional therapeutic target, with minimal known functional or disease associations, and no known drugs or biomarkers. If seeking a therapeutic target, refer to PKD2L2 (the protein-coding gene)[5].